GLPBio

c-RET

Read More about this category

The c-RET proto-oncogene, which was originally identified as a transforming gene by transfection of T-cell lymphoma DNA into NIH3T3 cells, is a member of the receptor tyrosine kinase (RTK) gene superfamily that encodes a receptor tyrosine kinase involved in the regulation of glial cell line-derived neurotrophic factor (GDNF) signaling. Signaling proteins, such as Grb7/Grb10, PLCγ, Shc/Enigma and Grb2, are recruited by activated c-RET protein through binding to the phosphorylated tyrosine residues in c-RET protein’s COOH-terminal sequence, Y905, Y1015, Y1062 and Y1096 respectively.  Moreover, results of in vivo studies suggest mutations of c-RET have been implicated in tumorigenesis, in which c-RET mRNA and/or protein have been found in tumors of neuroectodermal origin as well as in human neuroblastoma cell lines.

Products Related to c-RET(8)

  • GC10035 structure
    GC10035TG101209
    CAS: 936091-14-4
    Purity: >99.50%

    An inhibitor of JAK2, FLT3, RET, and JAK3

  • GC13194 structure
    GC13194RPI-1
    CAS: 269730-03-2
    Purity: >98.50%

    RPI-1 es un inhibidor especÍfico de la tirosina cinasa de 2-indolinona Ret disponible por vÍa oral. RPI-1 inhibe la proliferaciÓn, la fosforilaciÓn de tirosina Ret, la expresiÓn de proteÍna Ret y la activaciÓn de PLCgamma, ERK y AKT en células TT de carcinoma medular de tiroides humano. Actividad antitumoral.

  • GC14534 structure
    GC14534Regorafenib monohydrate
    CAS: 1019206-88-2
    Purity: >99.50%

    A multi-kinase inhibitor

  • GC14606 structure
    GC14606Regorafenib hydrochloride
    CAS: 835621-07-3
    Purity: >99.50%

    A multi-kinase inhibitor

  • GC15217 structure
    GC15217Danusertib (PHA-739358)
    CAS: 827318-97-8
    Purity: >98.50%

    A pan-Aurora kinase and Abl inhibitor

  • GC15307 structure
    GC15307SU5416
    CAS: 204005-46-9
    Purity: >98.00%

    SU5416 es un potente inhibidor del receptor del factor de crecimiento endotelial vascular (VEGFR) de moléculas pequeñas.

  • GC16362 structure
    GC16362AD57 (hydrochloride)
    CAS: 2320261-72-9
    Purity: >98%

    polypharmacological cancer therapeutic that inhibits RET.

  • GC16391 structure
    GC16391Amuvatinib (MP-470, HPK 56)
    CAS: 850879-09-3
    Purity: >98.00%

    A multi-targeted RTK inhibitor